Exhibit 107
Calculation of Filing Fee Tables
Form S-8
(Form Type)
ASLAN Pharmaceuticals Limited
(Exact Name of Registrant as Specified in its Charter)
Table 1: Newly Registered Securities
Security Type | Security Class Title(1) | Fee Calculation Rule | Amount Registered(2) | Proposed Maximum Offering Price Per Unit | Maximum Aggregate Offering Price | Fee Rate | Amount of Registration Fee |
Equity | Ordinary Shares, $0.01 par value per share, ASLAN Pharmaceuticals Limited 2020 Equity Incentive Plan | Rule 457(c) and Rule 457(h) | 13,948,935(3) | $0.17(4) | $2,371,318.95(4) | 0.0000927 | $219.83 |
Total Offering Amounts |
| $2,371,318.95 |
| $219.83 | |||
Total Fee Offsets |
|
|
| - | |||
Net Fee Due |
|
|
| $219.83 | |||
| (1) | These ordinary shares, par value $0.01 per share (“Ordinary Shares”), may be represented by the American Depositary Shares (“ADSs”) of ASLAN Pharmaceuticals Limited (the “Registrant”), each of which represents five Ordinary Shares. The Registrant’s ADSs issuable upon deposit of the Ordinary Shares registered hereby have been registered under separate registration statements on Form F-6 (File Nos. 333-224273 and 333-248632). |
| (2) | Pursuant to Rule 416(a) under the Securities Act of 1933, as amended (the “Securities Act”), this Registration Statement shall also cover any additional Ordinary Shares that become issuable under the ASLAN Pharmaceuticals Limited 2020 Equity Incentive Plan (the “2020 Plan”) by reason of any stock dividend, stock split, recapitalization or other similar transaction. |
| (3) | Represents 13,948,935 Ordinary Shares (an equivalent of 2,789,787 ADSs) reserved for future issuance pursuant to restricted stock awards, stock options and other equity-based awards under the 2020 Plan. The number of Ordinary Shares reserved for issuance under the 2020 Plan will automatically increase on January 1st of each year, commencing on January 1, 2022 and ending on (and including) January 1, 2030, by an amount equal to the 4% of the total number of the Registrant’s Ordinary Shares outstanding on December 31st of the preceding calendar year, or such fewer number of Ordinary Shares as determined by the Registrant’s board of directors. |
| (4) | Estimated in accordance with Rule 457(c) and Rule 457(h) of the Securities Act solely for purposes of calculating the registration fee, and is based upon the price of $0.17 per ordinary share (or $0.85 per ADS, which was the average of the high and low prices of the Registrant’s ADSs as reported on the Nasdaq Global Market for March 23, 2022. |
